Evidence map›Paper›PMID 35732734›Full record

ArticleNature2022

Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.

Tian-Tian Liu, Sunkyung Kim, Pritesh Desai, Do-Hyun Kim, Xiao Huang, Stephen T Ferris, Renee Wu, Feiya Ou, Takeshi Egawa, Steven J Van Dyken and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Priming of CD8Nature neuroscience · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The DC1 conundrum: Do type I dendritic cells make or break allograft tolerance?American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Review
  13. Article
  14. Article
  15. Intratumoral TScience immunology · 2026
    Article
  16. CD8bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Tian-Tian LiuDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0001-9377-9938
Sunkyung KimDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
Pritesh DesaiDepartment of Medicine, Washington University in St Louis, School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0002-4697-9475
Do-Hyun KimDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
Xiao HuangDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
Stephen T FerrisDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-3340-2607
Renee WuDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
Feiya OuDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
Takeshi EgawaDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
Steven J Van DykenDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0002-9787-0883
Michael S DiamondDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0002-8791-3165
Peter F JohnsonMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-4145-4725
Masato KuboDivision of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Noda, Japan.ORCID http://orcid.org/0000-0001-7867-3086
Theresa L MurphyDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
Kenneth M MurphyDepartment of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA. kmurphy@wustl.edu.ORCID http://orcid.org/0000-0002-3505-9630
Washington University in St. Louis · USNational Cancer Institute · USTokyo University of Science · JP

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
Control of Oncogenic Signaling Through Spatial Organization of Kinases and mRNAsZIABC012098 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JOHNSON, PETER F · 2022 to 2025
$6.0M
The transcription factor c-MYC in lymphocyte expansion and restriction of stemnessR01AI130152 · NIAID · WASHINGTON UNIVERSITY · PI Takeshi Egawa · 2017 to 2026
$4.6M
Molecular Basis of cDC1 DevelopmentR01AI162643 · NIAID · WASHINGTON UNIVERSITY · PI MURPHY, KENNETH M · 2022 to 2025
$2.8M
Systemic Neurotropic virus infection effects on GI DysmotilityR01DK122790 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DIAMOND, MICHAEL S, HANDLEY, SCOTT A. · 2020 to 2023
$2.7M
Function of Wdfy4 in cross-presentation and immunityR01AI150297 · NIAID · WASHINGTON UNIVERSITY · PI MURPHY, KENNETH M · 2019 to 2023
$2.5M
Understanding the Mechanisms of DC Licensing in CD8 T Cell PrimingR01CA248919 · NCI · WASHINGTON UNIVERSITY · PI MURPHY, KENNETH M · 2021 to 2025
$2.3M
Targeting chitin in fibrotic lung diseaseR01HL148033 · NHLBI · WASHINGTON UNIVERSITY · PI VAN DYKEN, STEVEN · 2020 to 2023
$1.7M
Mechanism of c-MYC repression by IRF8 in myeloid lineagesR21AI164142 · NIAID · WASHINGTON UNIVERSITY · PI MURPHY, KENNETH M · 2021 to 2022
$433k
Transcriptional basis of embryonic macrophage developmentR21AI163421 · NIAID · WASHINGTON UNIVERSITY · PI MURPHY, KENNETH M · 2022 to 2023
$430k
The role of type 1 dendritic cells in CD4 and CD8 T cell anti-tumor immunityF30CA247262 · NCI · WASHINGTON UNIVERSITY · PI WU, RENEE PAULA · 2021 to 2023
$117k
Intramural NIH HHSNCI NIH HHS F30 CA247262NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA248919NHLBI NIH HHS R01 HL148033NIAID NIH HHS R01 AI130152NIAID NIH HHS R01 AI150297NIAID NIH HHS R01 AI162643NIAID NIH HHS R21 AI163421NIAID NIH HHS R21 AI164142NIDDK NIH HHS R01 DK122790NIGMS NIH HHS T32 GM007200NIH HHS 5T32 GM007200
6 · The paper itself

Abstract

The divergence of the common dendritic cell progenitor

Indexed as

Cell DifferentiationDendritic CellsEnhancer Elements, GeneticMutationZinc Finger E-box Binding Homeobox 2AnimalsBasic-Leucine Zipper Transcription FactorsCCAAT-Enhancer-Binding ProteinsEpistasis, GeneticInhibitor of Differentiation Protein 2LymphocytesMiceMyeloid CellsNematospiroides dubiusRepressor ProteinsTh2 CellsBasic-Leucine Zipper Transcription FactorsCCAAT-Enhancer-Binding ProteinsIdb2 protein, mouseInhibitor of Differentiation Protein 2Nfil3 protein, mouseRepressor ProteinsSNFT protein, mouseZEB2 protein, mouseZinc Finger E-box Binding Homeobox 2

Identifiers

PMID35732734
PMCPMC10358283
OpenAlexW4283275063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.